US$ 22.36
bpc-157 / tb4 Blend 5mg/5mg infiniwell bpc 157 rapid vs
Description
Treatment of Leber's optic atrophy
BPC-157 has never undergone human clinical trials for any indication no phase 1 safety data, no pharmacokinetic studies, no efficacy trials

By healing the gut lining and decreasing inflammation, the peptide provides a protective layer against drug-induced damage, thus improving the bodys resilience to the negative effects of some pharmaceuticals

[Vaccine 2016]
